Clinical Trials Logo

Clinical Trial Summary

The purpose of the present study is to elucidate the spectrum of ocular flora and their antimicrobial susceptibility profiles in patients undergoing routine cataract surgery.


Clinical Trial Description

A conjunctival and palpebral swab will executed at least 14 days before routine cataract surgery. Isolates will be identified using standard microbiological protocols. In vitro susceptibility will be determined using a breakpoint minimal inhibitory concentrations. In case of positivity, the swab will be repeated the day of surgery. Topical antibiotic may be used in case of positivity at the discretion of the surgeon. Descriptive statistics will be calculated. ;


Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms

  • Cataract
  • Disorders of the Eye Following Cataract Surgery

NCT number NCT02124603
Study type Observational
Source SIFI SpA
Contact
Status Completed
Phase N/A
Start date April 2014
Completion date October 2014

See also
  Status Clinical Trial Phase
Recruiting NCT05147233 - OCS-01: A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery Phase 3